ABHINAV SINGH
Allopathic & Osteopathic Physicians|Internal Medicine RUIDOSO, NM NPI 1194841254
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NM Lilly USA, LLC All categories
General Payments — all program years on this page
$777.30
- Category: General Payments
- Program years: PY2019–2024
- Record count: 51
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $176.76 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.76 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $102.91 | 5 |
| Acerta Pharma LLC | $35.95 | 2 |
| ABBVIE INC. | $23.64 | 1 |
| Vanda Pharmaceuticals Inc. | $14.26 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104445771 | AstraZeneca Pharmaceuticals LP | $21.00 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105299628 | AstraZeneca Pharmaceuticals LP | $14.95 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106108758 | ABBVIE INC. | $23.64 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133920735 | Vanda Pharmaceuticals Inc. | $14.26 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136004781 | Lilly USA, LLC | $17.91 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136005123 | Lilly USA, LLC | $22.26 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136006101 | Lilly USA, LLC | $22.41 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136006103 | Lilly USA, LLC | $15.98 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136006413 | Lilly USA, LLC | $24.35 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.